Product Information
OMEGA-3 ETHYL ESTERS 1 GM CAP is a generic product labeled by Strides Pharma Inc., priced at $0.1711 per EA under NDC 64380076111. Its NADAC has been published 386 times since May 15, 2019.
FDA first approved this application on Sep 19, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
900 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380076111
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OMEGA-3-ACID ETHYL ESTERSApproval Type
Generic (ANDA)
FDA Application
ANDA203893FDA Approved
9/19/2017
TE Code
AB
On Market Since
1/18/2019
Pharmacological Classes
Price Statistics
The NADAC for OMEGA-3 ETHYL ESTERS 1 GM CAP has been published 386 times since May 15, 2019, and over the history we have for it it has declined 33.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1711 per EA |
|---|---|
| All-time high | $0.2890 (Sep 11, 2019) |
| All-time low | $0.1537 (Jan 18, 2023) |
| 52-week high | $0.1726 |
| 52-week low | $0.1652 |
| Median price | $0.1797 |
| Average price | $0.1947 |
| Largest weekly change | -19.9% (Mar 17, 2021) |
| Weeks tracked | 386 |
| Tracking since | May 15, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
omega-3-acid ethyl esters market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Omega-3 Fatty Acid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMEGA-3 ETHYL ESTERS 1 GM CAP?
The current National Average Drug Acquisition Cost (NADAC) for OMEGA-3 ETHYL ESTERS 1 GM CAP, manufactured by Strides Pharma Inc., is $0.1711 per EA (NDC 64380076111), effective Sep 30, 2026.
How has the price of OMEGA-3 ETHYL ESTERS 1 GM CAP changed over time?
Over the history we have for it, the NADAC for OMEGA-3 ETHYL ESTERS 1 GM CAP has declined 33.3%. It has been tracked across 386 weekly CMS publications since May 15, 2019.
What are the highest and lowest recorded NADAC prices for OMEGA-3 ETHYL ESTERS 1 GM CAP?
Since May 15, 2019, the NADAC for OMEGA-3 ETHYL ESTERS 1 GM CAP has ranged from a low of $0.1537 (Jan 18, 2023) to a high of $0.2890 (Sep 11, 2019), with a median of $0.1797 per EA.
Are there cheaper alternatives to OMEGA-3 ETHYL ESTERS 1 GM CAP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OMEGA-3 ETHYL ESTERS 1 GM CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures OMEGA-3 ETHYL ESTERS 1 GM CAP?
OMEGA-3 ETHYL ESTERS 1 GM CAP (NDC 64380076111) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.